- Advertise
- Contact Us
- Editorial Contacts
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Applied Clinical Trials-03-01-2011
Applied Clinical Trials
Applied Clinical Trials Digital Edition - March 2011, Supplement
March 01, 2011
Issue PDF
20
3
Partnerships in Clinical Trials
Applied Clinical Trials Digital Edition - March 2011
March 01, 2011
Issue PDF
20
3
TRIAL DESIGN : Rare Disease Research and Patient Registries Safety: Drug Exposures in Expectant Mothers SUBJECT RECRUITMENT : How to Raise Accrual Rates in Cancer Trials Also in this issue : FDA?s Sentinel System, Clinical Trials Directive, One Hundred Percent Source Data Verification, Understanding Medication Non-Adherence
Business and News Update March 2011
March 01, 2011
Business News
20
3
Industry news focusing on the people and organizations who work in the clinical trials profession.
Cancer Trials: Raising Accrual Rates
March 01, 2011
Feature Article
20
3
Lessons learned from the recruitment of colorectal cander patients into clinical trials.
Revisions to the Clinical Trials Directive
March 01, 2011
View from Brussels
20
3
The European Union is accepting input regarding changes to the directive until the end of May.
Palm Beach CRO and AOBO Form Partnership
March 01, 2011
News
20
3
Chinese pharmaceutical company forms alliance with American CRO.
Low Hanging Fruit in the Fight Against Inefficiency
March 01, 2011
Clinical Trial Insights
20
3
Direction from regulatory agencies would help eradicate wasteful 100 percent source data verification.
Researchers Explore Uses of Health System Data
March 01, 2011
View from Washington
20
3
FDA's Sentinel Initiative sets pace for tapping e-health records for product assessment.
Biomarkers and Targeted Therapies Usage
March 01, 2011
20
3
A 2010 survey conducted by the Tufts Center for the Study of Drug Development (Tufts CSDD) finds that sponsor companies are allocating resources, modifying organizational structures, and increasing investment in the development of personalized medicines (i.e., tailoring of medical treatment and healthcare delivery based on individual patient characteristics including genetic, molecular, and imaging).
Monitoring Drug Exposure in Pregnancy
March 01, 2011
Feature Article
20
3
Post-approval methods for monitoring the safety of drug exposures in expectant mothers.
Orphan Drug Designationas and Cystic Fibrosis
March 01, 2011
Therapeutic Corner
20
3
News from the Orphan Drug workshop.
Pfizer Closure Deals Serious Blow to Europe
March 01, 2011
Global News
20
3
The recent shutdown of the R&D facility should signify a warning to the British science community.
Todos Juntos por la Salud
March 01, 2011
Partnerships in Clinical Trials
20
3
A MMG strategic initaitve to address disparities in clinical research participation among Hispanic and Latino communities.
Understanding Non-Adherence
March 01, 2011
A Closing Thought
20
3
Inappropriate calendar pacakaging is a common occurrence leading to confusion and mistakes.
Patient Registries and Rare Diseases
March 01, 2011
Feature Article
20
3
Researchers are turning to patient registries to fill rare-disease knowledge gaps.